等待开盘 11-04 09:30:00 美东时间
+0.310
+2.07%
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
Raymond James analyst Gary Nachman reiterates Bausch & Lomb (NYSE:BLCO) with a Outperform and raises the price target from $18 to $19.
10-30 22:32
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Bausch & Lomb (TSX:BLCO) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.16 by 12.5 percent. This is a 5.88 percent increase over earnings of $0.17 per share from the same
10-29 18:59
中新经纬10月27日电 (王玉玲)27日,有消息称,诺华与康哲维盛签署战略合作协议,前者将两款眼科产品在中国的独家进口、商业推广和分销权转让给康哲维盛。 ...
10-27 17:01
文 | vb动脉网 在中国医疗器械版图上,总有一些赛道长期“空白”,并非因为市场太小,而是因为“太难”。 过去十年里,中国企业已陆续攻下了眼科手术显微镜、眼底...
10-21 19:48
https://www.wsj.com/business/deals/activist-jana-takes-stake-in-cooper-a-maker-of-medical-devices-20ffbe9c
10-20 16:52
今日重点评级关注:Maxim Group:维持Gain Therapeutics"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Icecure Medical"买入"评级,目标价从2美元升至2.5美元
10-08 09:14
今日重点评级关注:JMP证券:维持Ocular Therapeutix"跑赢大市"评级,目标价从20美元升至29美元;汇丰银行:上调Banco BBVA Argentina评级至"买入",目标价从21美元下调至17美元
10-02 15:08